PTC’s Translarna receives conditional approval for nonsense mutation DMD in EU
The European Commission has given conditional marketing authorisation for biopharmaceutical company PTC Therapeutics' Translarna (ataluren) in the EU. Translarna is a treatment for the...
Pharmaceuticals Learning the Language of the New Healthcare Landscape
With monumental health reform coming into effect, the pharmaceutical industry is learning to speak a second language. Clinical efficacy is no longer the sole...
LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment
LSI Medience Corporation today announced that the company has signed an Agreement with Kineticos, a Raleigh-Durham, NC based life sciences consulting company. Kineticos will...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...